Expert Review of Endocrinology & Metabolism

期刊简介：Expert Review of Endocrinology & Metabolism [ISSN 1744-6651]; [e-ISSN 1744-8417] is a MEDLINE-indexed, peer-reviewed journal providing extensive coverage of state-of-the-art research and clinical advancements in endocrine control and metabolism. The journal is an essential contribution to decision-making for disorders of endocrinology and metabolism for all professionals within this specialty, encompassing the most stimulating and up-to-date topics in clinical diseases such as: diabetes, obesity, osteoporosis, thyroid disease, adrenal insufficiency and pituitary tumors, as well as disorders associated with growth, reproduction, weight management and hormone-regulated gene expression. The journal focuses on the following key areas: Screening, prevention and diagnostics Existing and novel therapeutics Related molecular genetics Pathophysiology Epidemiology The journal welcomes clinically focused original research, reviews, editorials and drug profile articles. Please note that the journal does not accept case reports or case series and does not accept papers focused on pre-clinical work and/or animal studies. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Reach an international clinical and medical audience alongside other key opinion leaders in your field by publishing with Expert Review of Endocrinology & Metabolism , part of the Expert Collection brand. Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services. For any pre-submission enquiries, please contact the Commissioning Editor.

【译文】内分泌与代谢专家评论 [ISSN 1744-6651]； [e-ISSN 1744-8417] 是一本 MEDLINE 索引的同行评审期刊，广泛报道内分泌控制和代谢方面的最新研究和临床进展。该杂志对该专业所有专业人士的内分泌和代谢疾病决策做出了重要贡献，涵盖临床疾病中最刺激和最新的主题，例如：糖尿病、肥胖、骨质疏松症、甲状腺疾病、肾上腺功能不全和垂体瘤，以及与生长、生殖、体重管理和激素调节基因表达相关的疾病。该杂志重点关注以下关键领域： 筛查、预防和诊断 现有和新型疗法 相关分子遗传学 病理生理学 流行病学 该杂志欢迎以临床为重点的原创研究、评论、社论和药物简介文章。请注意，该期刊不接受病例报告或病例系列，也不接受专注于临床前工作和/或动物研究的论文。一旦编辑团队评估了您的论文的适用性，它将由独立的专家审稿人进行双重匿名同行评审。通过《内分泌与代谢专家评论》（专家合集品牌的一部分）发表文章，吸引国际临床和医学受众以及您所在领域的其他关键意见领袖。作者可以选择在本期刊上发表黄金开放获取，也可以选择使用我们的加速出版服务进行发表。对于提交前的任何疑问，请联系委托编辑。